-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Reiterates Buy on Compass Therapeuticsto Buy

Benzinga·04/22/2025 13:21:42
Listen to the news
Guggenheim analyst Michael Schmidt reiterates Compass Therapeutics (NASDAQ:CMPX) from Buy to Buy.